Identification of potential biomarkers for breast cancer based on salivary metabolomics
The salivary metabolome of breast cancer patients displays distinct changes compared to healthy individuals. Salivary 2-aminonicotinic acid and theobromine emerge as promising non-invasive biomarkers for breast cancer detection. Nevertheless, larger-scale validation studies are warranted to substantiate their specificity and clinical utility.
Authors
- Yang Li (ORCID: https://orcid.org/0000-0001-6710-9471)
- Kai Ming Yang (ORCID: https://orcid.org/0000-0003-1059-0705)
- Xinyu Jiang (ORCID: https://orcid.org/0000-0001-6820-231X)
- Yumei Jia (ORCID: https://orcid.org/0000-0001-8718-5105)
- Bo Zhang (ORCID: https://orcid.org/0009-0009-0403-3575)
Institutions
- Central South University (CN)
- Hunan University of Traditional Chinese Medicine (CN)
- Hunan Cancer Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-10-10
- DOI
- https://doi.org/10.3389/fonc.2025.1655213
- Citations
- 2
- Primary Topic
- Metabolomics and Mass Spectrometry Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.61